Dementia-friendly Apothecaries as a Resource for Mental Heath in the Elderly
Demenz-freundliche Apotheken Als Ressource für Psychische Gesundheit im Alter
Ludwig-Maximilians - University of Munich
1,020 participants
Jul 1, 2025
OBSERVATIONAL
Conditions
Summary
The DARE study (Dementia-Friendly Apothecaries as a Resource for Mental Health in the Elderly) is a multicenter, prospective cohort study aiming to identify individuals with cognitive impairments early in pharmacies and enhance their access to support services. Partner pharmacies are equipped with memory test stations, and pharmaceutical staff are trained to guide participants. The digital memory test evaluates cognitive, psychosocial, and health factors, displaying results in a traffic light graphic. Participants with concerning results are referred to specialists or support services. The study's primary goals are to establish pharmacies as dementia screening hubs, improve care for affected individuals, promote interdisciplinary collaboration, and lay the groundwork for legal and billing frameworks. An optional subproject validates the screening through neurological evaluations.
Eligibility
Inclusion Criteria4
- Age: Participants must be 60 years or older at the time of consent.
- Language Proficiency: Sufficient knowledge of the German language to understand instructions and participate in the study.
- Cognitive Status: Presence of self-reported, relative-reported, or pharmacist-identified cognitive impairments (e.g., memory problems or mild cognitive changes).
- Consent: Ability to provide informed consent voluntarily.
Exclusion Criteria4
- Severe Sensory Impairments: Participants unable to see or hear well enough to complete the digital assessments or questionnaires.
- Previous Dementia Diagnosis: Individuals with a prior formal diagnosis of dementia, whether with or without underlying pathology.
- Severe Cognitive or Physical Impairments: Any condition that would prevent meaningful participation in the digital tests or structured screening process.
- These criteria aim to ensure that the study includes participants at risk of early cognitive decline while excluding those for whom the interventions or assessments would not be feasible or relevant.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07504965